Comparison of the anti-plaque and anti-gingivitis efficacy of Chlorhexidine and Malva mouthwashes: Randomized crossover clinical trial
- PMID: 39173823
- DOI: 10.1016/j.jdent.2024.105313
Comparison of the anti-plaque and anti-gingivitis efficacy of Chlorhexidine and Malva mouthwashes: Randomized crossover clinical trial
Abstract
Objectives: Although mechanical oral hygiene is widely practiced, it faces several challenges. Mouthwashes, such as chlorhexidine (CHX), are being explored as adjuncts to biofilm control, but their prolonged use has several side effects. Consequently, there is ongoing research into natural alternatives. This randomized crossover clinical study aimed to compare the antiplaque and antigingivitis efficacy of 0.12 % CHX and a 5 % Malva sylvestris.
Methods: Forty-four participants were involved in two phases, each comprising three stages with variations in the mouthwash solution used only. During the study, participants refrained from mechanical plaque removal for seven days. At first day, they received whole-mouth prophylaxis and oral health assessment. After three days, gingival inflammation assessment and prophylaxis in were performed in contralateral quadrants. Participants then used a randomly assigned mouthwash solution for four days. On the 7th day, they completed a questionnaire about their perception and appreciation of the mouthwash. Additionally, gingival inflammation and plaque index were also performed by a calibrated examiner. After a minimum 21-day washout period, participants entered the second phase, repeating the three stages.
Results: Results showed no statistically significant differences between the Malva sylvestris and CHX groups regarding inflammation and plaque formation. However, CHX demonstrated a significantly greater mean reduction (7th - 4th day) in gingival inflammation compared to Malva (p = 0.02) (0.01 ± 0.19 and 0.00 ± 0.19, respectively). Additionally, participants using CHX reported a more pleasant taste and considered higher plaque control perception (p < 0.05).
Conclusions: In conclusion, both products exhibited similar antiplaque effects, but CHX outperformed Malva in controlling gingival inflammation.
Clinical significance: Mouthwashes with Malva sylvestris may be a good alternative, in a short-term period, to control biofilm. However, lower antigingivitis efficacy may be expected when compared to chlorhexidine.
Keywords: Chlorhexidine; Clinical trial; Dental plaque; Gingivitis; Malva; Periodontal diseases.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors report no conflict of interest related to this study.
Similar articles
-
Clinical efficacy of green tea, aloe vera and chlorhexidine mouthwashes in the treatment of dental biofilm induced gingivitis: A multi-arm, double-blinded, randomized controlled clinical trial.Int J Dent Hyg. 2024 Aug;22(3):504-513. doi: 10.1111/idh.12664. Epub 2023 Jan 23. Int J Dent Hyg. 2024. PMID: 36583292 Clinical Trial.
-
Efficacy of 0.05% cetylpyridinium chloride mouthwash as an adjunct to toothbrushing compared with 0.12% chlorhexidine gluconate mouthwash in reducing dental plaque and gingival inflammation: A randomized control trial.Int J Dent Hyg. 2023 Feb;21(1):195-202. doi: 10.1111/idh.12614. Epub 2022 Aug 17. Int J Dent Hyg. 2023. PMID: 35946123 Clinical Trial.
-
Comparative evaluation of the efficacy of probiotic, Aloe vera, povidine-iodine, and chlorhexidine mouthwashes in the treatment of gingival inflammation: A randomized controlled trial.Dent Med Probl. 2024 Mar-Apr;61(2):181-190. doi: 10.17219/dmp/156425. Dent Med Probl. 2024. PMID: 38652926 Clinical Trial.
-
Efficacy of propolis-based mouthwashes on dental plaque and gingival inflammation: a systematic review.BMC Oral Health. 2020 Jul 10;20(1):198. doi: 10.1186/s12903-020-01185-5. BMC Oral Health. 2020. PMID: 32650754 Free PMC article.
-
The efficacy of mouthwashes on oral microorganisms and gingivitis in patients undergoing orthodontic treatment: a systematic review and meta-analysis.BMC Oral Health. 2023 Apr 6;23(1):204. doi: 10.1186/s12903-023-02920-4. BMC Oral Health. 2023. PMID: 37024817 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical